Vaccine Value

The Vaccine Value research group estimates the health, economic, and equity impacts of vaccination programmes, including benefit-risk profiles, stakeholder acceptability, and vaccine-preventable antimicrobial resistance. We partner with national, regional, and global stakeholders to inform new vaccine introductions and support the efficient, equitable scale-up of existing vaccines.